EUR 0,00
(toimituskulut: 0,00)
La Roche-Posay Sunscreen cream 50 ml
Tuotenumero: [7352334] | Valmistaja: La Roche-Posay | EAN: 3337875545891
Päävarastossa
Päävarastossa. Tilaa ennen klo 15:00 niin pyrimme lähettämään tuotteen tänään. (arkipäivisin) Lisätietoja
VARASTOTARJOUS
Tuotetta on päävarastossa 17 kappaletta
Nykyinen hinta on voimassa niin kauan kuin erää on jäljellä varastossa.
Toimitusvaihtoehdot - Valitaan kassalla
Budbee Laatikko - Nouda valitsemastasi laatikosta!
7,02
Bring - Toimitus huoltopisteeseen
7,02
Bring - Kotiinkuljetus -arkisin.
10,03
Toimituskulut on laskettu vastaanottajan postinumeron perusteella:00180 - Helsinki Vaihda postinumero
Syötä postinumero toimitusta varten:
EUR
17,17
ilman ALV 13,68
Kokonaishinta sis. toimitus
24,19
Tämä toiminto vaatii sisäänkirjautumisen. Luo käyttäjä ja voit käyttää listojamme esim. säännöllisiä ostoksia ja toivelistoja varten
Luo käyttäjä
Kirjaudu
Luo käyttäjä
Kirjaudu
Send på mail
Double anti-shine action: immediate absorption and ultra-dry finish.
Its universal micro-pigments melt into skin, adapting to every skintone for a naturally fresh and luminous complexion. Non-greasy.
La Roche-Posay Suncare Expertise
Forming the majority of UV rays and present all year round, long UVA penetrate to the very heart of the dermic causing irreversible skin damage. For the first time La Roche-Posay incorporates BAICALIN antioxidant, and demonstrates its biological efficacy against the effects of UV (including long UVA) for extra protection.
DERMATOLOGICALLY TESTED
Anthelios efficacy has been demonstrated via clinical studies carried out in-vivo on subjects suffering from sun intolerances, particularly those caused by UVA rays. Anthelios products all have a high PPD (Persistent Pigment Darkening) factor, offering one of the best protections against UVA offered by any brand in the world. The efficacy has been proven by a file of 16 clinical studies carried out by world-renowned expert dermatologists. The brand was also the first laboratory to use Mexoryl XL and Mexoryl SX and the first to use photostable UVA filters in its sun protection.
9/10 of dermatologists would recommend Anthelios*
MINIMALIST HYPO-ALLERGENIC FORMULA
The minimalist formula contains the best of our creations – designed for sensitive skin and all of its needs. Tested and re-tested for its efficacy and mildness on sensitive skin. It is also hypoallergenic.
This is a cosmetic product. For medical conditions seek advice from your GP
*Survey conducted on 249 dermatologists who chose to attend a La Roche-Posay sponsored symposium in the UK, July 2016
Its universal micro-pigments melt into skin, adapting to every skintone for a naturally fresh and luminous complexion. Non-greasy.
La Roche-Posay Suncare Expertise
Forming the majority of UV rays and present all year round, long UVA penetrate to the very heart of the dermic causing irreversible skin damage. For the first time La Roche-Posay incorporates BAICALIN antioxidant, and demonstrates its biological efficacy against the effects of UV (including long UVA) for extra protection.
DERMATOLOGICALLY TESTED
Anthelios efficacy has been demonstrated via clinical studies carried out in-vivo on subjects suffering from sun intolerances, particularly those caused by UVA rays. Anthelios products all have a high PPD (Persistent Pigment Darkening) factor, offering one of the best protections against UVA offered by any brand in the world. The efficacy has been proven by a file of 16 clinical studies carried out by world-renowned expert dermatologists. The brand was also the first laboratory to use Mexoryl XL and Mexoryl SX and the first to use photostable UVA filters in its sun protection.
9/10 of dermatologists would recommend Anthelios*
MINIMALIST HYPO-ALLERGENIC FORMULA
The minimalist formula contains the best of our creations – designed for sensitive skin and all of its needs. Tested and re-tested for its efficacy and mildness on sensitive skin. It is also hypoallergenic.
This is a cosmetic product. For medical conditions seek advice from your GP
*Survey conducted on 249 dermatologists who chose to attend a La Roche-Posay sponsored symposium in the UK, July 2016